The revered US film buff and longtime Chicago Sun-Times contributor died on Thursday.
Ebert was first diagnosed with thyroid cancer in 2002 and during a hospital stay last year doctors discovered the return of cancerous cells in his body.
Also Read
"The 'painful fracture' that made it difficult for me to walk has recently been revealed to be a cancer. It is being treated with radiation, which has made it impossible for me to attend as many movies as I used to... My intent is to continue to write selected reviews but to leave the rest to a talented team of writers handpicked and greatly admired by me...
"In addition to writing about movies, I may write about what it's like to cope with health challenges and the limitations they can force upon you. It really stinks that the cancer has returned and that I have spent too many days in the hospital... So on this day of reflection I say again, thank you for going on this journey with me. I'll see you at the movies," he wrote.
Ebert also battled cancer in his salivary glands, because of which he lost his ability to speak and could not eat solid foods due to invasive jaw surgery.
Ebert was considered one of the world's leading film critics thanks to his long-running 'At The Movies' review show, which he fronted from the early 1980s until 2006. He became the first film critic to receive the Pulitzer Prize in 1975 and the first to be awarded a star on the Hollywood Walk of Fame.
Born in Illinois in 1942, the writer became editor and columnist for The Daily Illini at the University of Illinois. He began his professional career as a copy boy at the Sun-Times, and became the newspaper's movie critic at the age of 25.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
